Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Selecting Triple Negative Breast Cancer Patients for Immunotherapy

Surgical Oncology Clinics of North America(2023)10.1016/j.soc.2023.05.005Source: DataRank Database

Selecting Triple Negative Breast Cancer Patients for Immunotherapy is a research paper published in Surgical Oncology Clinics of North America (2023). On theSindex it has a DataRank of 0. It has been cited 1 time.

N/A

0DataRank · unranked

Scored on demand from live citation data

1 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 0.12)OA: closedTopics (27)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Elizabeth A. Mittendorf ORCID,Stephanie Downs‐Canner ORCID

Live enrichment

PubMed:37714640 OpenAlex:https://openalex.org/W4379279745

National Institutes of Health

Grant: 1K08CA259533-01A1

The role of B-cells in the anti-tumor immune response in triple negative breast cancer

NCI NIH HHS

Grant: K08 CA259533

FWCI

0.12

Citation Percentile

0.4%

Citation Trend

2024

closedLicense: Elsevier TDM

journalhttps://doi.org/10.1016/j.soc.2023.05.005

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37714640

Fields of Study

Cancer Immunotherapy and BiomarkersImmunotherapy and Immune ResponsesCancer Cells and Metastasis03 medical and health sciences0302 clinical medicine

MeSH Terms

HumansImmunotherapyPatient SelectionTriple Negative Breast Neoplasms

Keywords

MedicineTriple-negative breast cancerImmunotherapyBreast cancerAdverse effectChemotherapyOncologyStage (stratigraphy)Intensive care medicineCancer immunotherapyInternal medicineCancerTriple Negative Breast CancerNeoadjuvantPembrolizumabPatient SelectionHumansTriple Negative Breast Neoplasms

Sustainable Development Goals

SDG 0: Good health and well-being

Selecting Triple Negative Breast Cancer Patients for Immunotherapy

FAIR Checklist

Authors (2)

Funding (2 grants)

Impact

Open Access

Topics